4Filing Date: Dec 29, 2025
Becton Dickinson & (BDX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001628280-25-058843
Total Value$14.5K
Trades1
Insiders1
Transaction Details
Feld Michael
EVP, CRO & Pres. Life Sciences·Direct
Sell · Dispose
Common Stock
Shares-74
Price$196.08
Total Value$14.5K
Shares Owned After16.51K
Transaction DateDec 26, 2025
10b5-1
Post-Transaction Holdings
Feld Michael · EVP, CRO & Pres. Life Sciences
| Security | Shares | Change |
|---|---|---|
| Common Stock | 16.51K | -74 (-0.45%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2025-12-26
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
--- Reporting Owner ---
Name: Feld Michael
CIK: 0002034349
Role: Officer (EVP, CRO & Pres. Life Sciences)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2025-12-26 | Code: S (Open market sale)
Shares: -74 | Price: $196.08
Total Value: $14,509.92
Shares Owned After: 16,506 | Ownership: D (Direct)
--- Signature ---
/s/ Donna Kalazdy, by power of attorney from Michael Feld (2025-12-29)